Revance Therapeutics shares owned by Yarbrough Capital
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Yarbrough Capital
from 13F filings
Historical chart of Yarbrough Capital investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Yarbrough Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Yarbrough Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $60k | 12k | 4.92 |
| 2023-12-31 | $107k | 12k | 8.79 |
| 2023-09-30 | $140k | 12k | 11.47 |
| 2023-06-30 | $309k | 12k | 25.31 |
| 2023-03-31 | $393k | 12k | 32.21 |